Upgrade to SI Premium - Free Trial

Kymera Therapeutics (KYMR) PT Raised to $135 at Guggenheim

July 28, 2026 6:40 AM
(Updated - July 28, 2026 6:49 AM EDT)

Guggenheim analyst Brad Canino raised the price target on Kymera Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change